NCT03423901View on ClinicalTrials.gov

Impact of Anti-HLA Donor-specific Antibodies in ABO-incompatible Kidney Transplantation

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

February 6, 2018

Primary Completion Date

May 2, 2018

Study Completion Date

May 5, 2018

Conditions
Kidney Transplant
Interventions
OTHER

Blood sampling

Descriptive analysis of clinical, biological and histological of 3 arms: ABO incompatible, HLA incompatible, and ABO/HLA incompatible kidney transplantation (1 and 5 years posttransplantation in each groups)

Trial Locations (1)

31059

University Hospital, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT03423901 - Impact of Anti-HLA Donor-specific Antibodies in ABO-incompatible Kidney Transplantation | Biotech Hunter | Biotech Hunter